Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1950-1958
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1950
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1950
Table 1 Comparative analyses for clinical efficacy among all cohorts [cases (%)]
Cohort | Cure | Effective | Ineffective | Total effective rate |
Cohort A (n=20) | 11 (55.00) | 8 (40.00) | 1 (5.00) | 19 (95.00)a |
Cohort B (n=20) | 9 (45.00) | 7 (35.00) | 4 (20.00) | 16 (80.00) |
Cohort C (n=20) | 7 (35.00) | 5 (25.00) | 8 (40.00) | 12 (60.00) |
χ2 values | 7.267 | |||
P value | 0.026 |
Table 2 Comparative analyses for prognosis among all cohorts (x ± s)
Cohort | Time of first exhaust/defecation (d) | Length of hospital stay (d) | Gastrointestinal decompression time (d) | Relief time of abdominal pain (d) | Relief time of abdominal distention (d) |
Cohort A (n = 20) | 7.85 ± 1.53a,b | 15.30 ± 1.95c | 11.30 ± 1.84a,b | 2.05 ± 0.51a,b | 5.55 ± 1.79a,b |
Cohort B (n = 20) | 10.75 ± 2.86c | 17.10 ± 2.57c | 14.40 ± 2.74c | 3.00 ± 1.12 | 3.85 ± 1.09 |
Cohort C (n = 20) | 13.05 ± 1.90 | 20.25 ± 2.53 | 16.35 ± 1.60 | 3.60 ± 1.35 | 3.55 ± 1.10 |
F value | 28.749 | 22.381 | 28.933 | 10.923 | 12.458 |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Table 3 Comparative analyses for inflammatory factors levels pre-/post-therapy in all cohorts (x ± s)
Cohort | CRP (mg/L) | TNF-α (ng/L) | IL-6 (ng/L) | MCP-1 (ng/L) | ||||
Pre-therapy | Post-therapy | Pre-therapy | Post-therapy | Pre-therapy | Post-therapy | Pre- therapy | Post-therapy | |
Cohort A (n = 20) | 32.84 ± 3.90 | 17.14 ± 2.27a,b,c | 10.11 ± 1.74 | 2.62 ± 0.83a,b,c | 34.92 ± 2.31 | 15.27 ± 1.15a,b,c | 213.33 ± 14.91 | 122.91 ± 19.00a,b,c |
Cohort B (n = 20) | 34.40 ± 4.67 | 19.99 ± 3.51a,c | 11.03 ± 1.99 | 3.79 ± 1.06a,c | 35.59 ± 1.59 | 18.88 ± 1.58a,c | 215.24 ± 19.15 | 150.74 ± 19.76a,c |
Cohort C (n = 20) | 32.27 ± 2.78 | 25.16 ± 2.41a | 10.80 ± 2.06 | 5.35 ± 0.95a | 34.92 ± 3.09 | 23.43 ± 2.26a | 211.07 ± 16.46 | 167.83 ± 15.10a |
F value | 1.636 | 42.566 | 1.227 | 41.469 | 0.526 | 112.506 | 0.303 | 31.482 |
P value | 0.204 | < 0.001 | 0.301 | < 0.001 | 0.594 | < 0.001 | 0.740 | < 0.001 |
Table 4 Comparative analyses for nutritional status of all cohorts pre- and post-therapy (x ± s)
Cohort | Serum albumin (g/L) | Serum transferrin (g/L) | ||
Pre-therapy | Post-therapy | Pre-therapy | Post-therapy | |
Cohort A (n = 20) | 43.46 ± 3.33 | 49.88 ± 3.60a,c | 2.24 ± 0.53 | 3.55 ± 0.42a,b,c |
Cohort B (n = 20) | 42.79 ± 4.36 | 47.90 ± 3.90a | 2.02 ± 0.55 | 3.16 ± 0.23a |
Cohort C (n = 20) | 43.58 ± 2.14 | 46.68 ± 2.41a | 2.27 ± 0.49 | 2.13 ± 0.51a |
F value | 0.306 | 4.596 | 1.377 | 7.000 |
P value | 0.737 | 0.014 | 0.261 | 0.002 |
Table 5 Comparative analyses for adverse event occurrence among all cohorts [cases (%)]
Cohort | Anorexia | Vomiting | Tube obstruction | Rash | The total incidence of adverse reactions |
Cohort A (n = 20) | 1 (5.00) | 4 (20.00) | 0 (0.00) | 0 (0.00) | 5 (25.00) |
Cohort B (n = 20) | 1 (5.00) | 3 (15.00) | 1 (5.00) | 1 (5.00) | 6 (30.00) |
Cohort C (n = 20) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
Fisher’s exact probability value | 0.029 |
- Citation: Yang W, Pu J. Efficacy of ileus tube combined with meglumine diatrizoate in treating postoperative inflammatory bowel obstruction after surgery. World J Gastrointest Surg 2023; 15(9): 1950-1958
- URL: https://www.wjgnet.com/1948-9366/full/v15/i9/1950.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i9.1950